Table 2.
Distribution and follow-up depending on embolization device.
| Embolization device (n = ) |
Intraoperative events | 3-week survival (n = ) |
Echographic assessment | Histologic assessment |
|---|---|---|---|---|
| Free coil | ||||
| CA (3) | VF | 0 | — | Transmural infarct |
| RCA (1) | VF | 0 | — | Transmural infarct |
| Interlocking coil | ||||
| CA (2) | VF | 1 | LVEF decrease <15% | Nontransmural infarct |
| RCA (2) | VF | 1 | No dysfunction | No infarct |
| Gelatin sponge | ||||
| CA (3) | — | 3 | No dysfunction | Nontransmural infarct |
| RCA (1) | — | 1 | No dysfunction | No infarct |
| Balloon occlusion | ||||
| CA (2) | NSVT | 2 | No dysfunction | No infarct |
| RCA (2) | NSVT | 2 | No dysfunction | No infarct |
| Alcoholization | ||||
| CA (5) | VF | 4 | 15% decrease in LVEF | Transmural infarct |
| RCA (3) | CHF | 2 | RV dysfunction 15% decrease in LVEF |
Transmural infarct |
CA: circumflex artery; RCA: right coronary artery; LV: left ventricle; RV: right ventricle; VF: ventricular fibrillation; NSVT: nonsustained ventricular tachycardia; CHF: congestive heart failure.